Related Experiment Video
Updated: Oct 22, 2025

Author Spotlight: Innovating Thiol Quantification and Biomarker Detection for Oxidative Stress Research
Published on: June 28, 2024
Glutathione Participation in the Prevention of Cardiovascular Diseases
Deyamira Matuz-Mares1, Héctor Riveros-Rosas1, María Magdalena Vilchis-Landeros1
1Departamento de Bioquímica, Facultad de Medicina, Universidad Nacional Autónoma de México, Avenida Universidad 3000, Cd. Universitaria, Coyoacán, Ciudad de México 04510, Mexico.
Insights
Reduced glutathione (GSH) counteracts oxidative stress in cardiovascular diseases (CVD). This review explores GSH
Area of Science:
- Biochemistry
- Cardiology
- Molecular Biology
Background:
- Cardiovascular diseases (CVD) are a leading cause of global mortality.
- Oxidative stress, driven by reactive oxygen species (ROS) and reactive nitrogen species (RNS), exacerbates CVD.
- Key ROS/RNS include superoxide anion, hydroxyl radical, nitric oxide, hydrogen peroxide, hypochlorous acid, and peroxynitrite.
Purpose of the Study:
- To review the critical role of reduced glutathione (GSH) in mitigating oxidative stress in cardiovascular pathologies.
- To examine the synthesis and regeneration of GSH in vital organs like the heart and liver.
- To highlight GSH's importance in preventing or reducing detrimental ROS effects in CVD.
Main Methods:
- Literature review focusing on the biochemical mechanisms of oxidative stress in CVD.
- Analysis of studies detailing glutathione synthesis and regeneration pathways.
- Examination of research on the protective effects of GSH against ROS/RNS in cardiovascular conditions.
Main Results:
- Reduced glutathione (GSH) is a crucial endogenous antioxidant.
- GSH synthesis and regeneration are vital for cellular defense against oxidative damage in the heart and liver.
- Adequate GSH levels are associated with reduced severity and progression of cardiovascular diseases.
Conclusions:
- Glutathione plays a significant protective role against oxidative stress in cardiovascular diseases.
- Maintaining optimal GSH levels through synthesis and regeneration is essential for cardiovascular health.
- Targeting GSH pathways may offer therapeutic strategies for managing CVD.
Abstract:
Cardiovascular diseases (CVD) (such as occlusion of the coronary arteries, hypertensive heart diseases and strokes) are diseases that generate thousands of patients with a high mortality rate worldwide. Many of these cardiovascular pathologies, during their development, generate a state of oxidative stress that leads to a deterioration in the patient's conditions associated with the generation of reactive oxygen species (ROS) and reactive nitrogen species (RNS). Within these reactive species we find superoxide anion (O2•-), hydroxyl radical (•OH), nitric oxide (NO•), as well as other species of non-free radicals such as hydrogen peroxide (H2O2), hypochlorous acid (HClO) and peroxynitrite (ONOO-). A molecule that actively participates in counteracting the oxidizing effect of reactive species is reduced glutathione (GSH), a tripeptide that is present in all tissues and that its synthesis and/or regeneration is very important to be able to respond to the increase in oxidizing agents. In this review, we will address the role of glutathione, its synthesis in both the heart and the liver, and its importance in preventing or reducing deleterious ROS effects in cardiovascular diseases.
More Related Videos
Related Concept Videos
Phase II Reactions: Glutathione Conjugation and Mercapturic Acid Formation
Several distinctive characteristics distinguish glutathione conjugation from other phase II...
Atherosclerosis III: Management
Coronary Artery Disease IV: Preventive Measures
Sulfur Assimilation
Cancer Prevention
Some...
Coronary Artery Disease I: Introduction

